These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7054537)

  • 1. The diverse nature of cancer cells: one reason therapy can fail.
    Macek C
    JAMA; 1982 Jan 22-29; 247(4):417-8. PubMed ID: 7054537
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer: an epigenetic landscape.
    Dhanasekaran K; Arif M; Kundu TK
    Subcell Biochem; 2013; 61():399-417. PubMed ID: 23150260
    [No Abstract]   [Full Text] [Related]  

  • 3. Problems of somatic mutation and cancer.
    Frank SA; Nowak MA
    Bioessays; 2004 Mar; 26(3):291-9. PubMed ID: 14988930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The cancerous cell. Genetic abnormalities (oncogenes and anti-oncogenes), growth factors, apoptosis and dissemination factors, prognostic incidence].
    Favrot MC
    Rev Prat; 1997 May; 47(9):1029-36. PubMed ID: 9208695
    [No Abstract]   [Full Text] [Related]  

  • 5. Revisiting the Warburg effect in cancer cells with proteomics. The emergence of new approaches to diagnosis, prognosis and therapy.
    Scatena R; Bottoni P; Pontoglio A; Giardina B
    Proteomics Clin Appl; 2010 Feb; 4(2):143-58. PubMed ID: 21137040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis.
    Beauchemin N; Arabzadeh A
    Cancer Metastasis Rev; 2013 Dec; 32(3-4):643-71. PubMed ID: 23903773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. iPSCs from cancer cells: challenges and opportunities.
    Ramos-Mejia V; Fraga MF; Menendez P
    Trends Mol Med; 2012 May; 18(5):245-7. PubMed ID: 22521522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico modeling of cancer cell dissemination and metastasis.
    Wai LE; Narang V; Gouaillard A; Ng LG; Abastado JP
    Ann N Y Acad Sci; 2013 May; 1284():71-4. PubMed ID: 23651197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer risks and perspectives: molecular mechanisms.
    Aruoma OI; Bahorun T; Agnihotri AK
    Mutat Res; 2014 Oct; 768():1-5. PubMed ID: 25773923
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular profiling of human cancer: new opportunities.
    Englert CR; Petricoin EF; Krizman DB; Emmert-Buck MR
    Curr Opin Mol Ther; 1999 Dec; 1(6):712-9. PubMed ID: 19629868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How does a normal human cell become a cancer cell?
    Gan DD; Macaluso M; Cinti C; Khalili K; Giordano A
    J Exp Clin Cancer Res; 2003 Dec; 22(4):509-16. PubMed ID: 15053291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Problems of tumor progression: doubts or hopes at the turn of the Millennium?].
    Tímár J
    Orv Hetil; 2000 Apr; 141(17):891-9. PubMed ID: 10827469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional transcriptomics: an experimental basis for understanding the systems biology for cancer cells.
    Schäfer R; Tchernitsa OI; Györffy B; Serra V; Abdul-Ghani R; Lund P; Sers C
    Adv Enzyme Regul; 2007; 47():41-62. PubMed ID: 17335873
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibroblast activation protein α in tumor microenvironment: recent progression and implications (review).
    Zi F; He J; He D; Li Y; Yang L; Cai Z
    Mol Med Rep; 2015 May; 11(5):3203-11. PubMed ID: 25593080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs and other small silencing RNAs in cancer.
    Rovira C; Güida MC; Cayota A
    IUBMB Life; 2010 Dec; 62(12):859-68. PubMed ID: 21154820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EMT in carcinoma progression and dissemination: facts, unanswered questions, and clinical considerations.
    Bastid J
    Cancer Metastasis Rev; 2012 Jun; 31(1-2):277-83. PubMed ID: 22215472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer robustness: tumour tactics.
    Kitano H
    Nature; 2003 Nov; 426(6963):125. PubMed ID: 14614483
    [No Abstract]   [Full Text] [Related]  

  • 18. Intratumor heterogeneity: origins, clinical significance and optimal strategies for cancer treatment.
    Mangano A; Lianos GD; Mangano A; Boni L; Dionigi G
    Future Oncol; 2015; 11(4):561-4. PubMed ID: 25686113
    [No Abstract]   [Full Text] [Related]  

  • 19. Reference listings in cancer research.
    Oncol Res; 1995; 7(12):625-32. PubMed ID: 8704280
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer biology: gone but not forgotten.
    Sharpless NE; DePinho RA
    Nature; 2007 Feb; 445(7128):606-7. PubMed ID: 17251931
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.